To the Editor:
The hyperglycemic state occurring in diabetes mellitus is responsible for formation and accumulation of advanced glycation endproducts (AGEs) that participate in the pathogenesis of vascular complications of diabetes mellitus (1 ) . There is considerable interest in the receptors for AGEs (RAGE) found in many cell types, particularly those affected in diabetes. RAGE are members of the immunoglobulin family of cell surface molecules with a diverse repertoire of ligands. Interaction of AGEs with RAGE alters several cell functions through modulation of intracellular signaling, gene expression, and release of proinflammatory molecules and free radicals that contribute to the pathology of diabetic complications (2, 3 ) . A soluble form of RAGE (sRAGE) can be measured in peripheral blood, which could result from the expression of a RAGE splice gene variant that encodes an amino-terminally truncated form of the receptor and/or from the cleavage of the native membranous receptor (4 The results of these analyses are shown in Table 1 . Mean (SD) values for serum RAGE were significantly higher in patients with type 1 diabetes than in nondiabetic controls [1320 (459) and 1041 (392) ng/L, respectively; P Ͻ0.001]. Median values were similarly different between the two groups: 1343 and 953 ng/L, respectively, for patients with type 1 diabetes and controls (P Ͻ0.001). Circulating concentrations of sRAGE were also significantly higher in patients with type 1 diabetes with moderate/severe retinopathy than in controls (Table 1) ; however, values for diabetic patients with ocular complications did not differ significantly from the values for patients free of retinopathy. Finally, we found no associations between circulating concentrations of sRAGE and duration of diabetes (r ϭ Ϫ0.31), Hb A 1c concentrations (r ϭ Ϫ0.169), or hsCRP concentrations (r ϭ Ϫ0.228; not significant for all three).
Substantial evidence supports a role for AGE/RAGE interactions in the pathophysiology of diabetes. Accumulation of RAGE ligands, as occurs in the diabetic state, leads to enhancement of cellular expression of the receptor, thereby triggering cell dysfunction. Little is known about the regulatory aspects of RAGE and sRAGE gene expression; we can presume that in diabetes mellitus, increased formation of AGEs, which are positive regulators of cell expression of RAGE, enhances secretion of sRAGE in a similar manner. On the other hand, the lack of association between sRAGE concentrations and Hb A 1c values or diabetes duration is unexpected because these two variables have been shown to correlate with AGEs (6 ). The observed increase in sRAGE in diabetic patients, however, can be viewed as a protective reaction to counterbalance, at least partly, the increase in AGE formation in these patients. Recently, Falcone et al. (7 ) reported low concentrations of sRAGE in plasma in nondiabetic patients with coronary artery disease. This result does not disagree with ours, if we consider that the soluble isoform of RAGE could play an antagonistic role by competing with the cell-surface receptor. However, the pathophysiologic mechanisms that are responsible for the increase in circulating concentrations of sRAGE in diabetes or its decrease in coronary artery disease remain to be clarified.
Finally, although our cohort of patients with retinopathy was limited, we failed to observe a significant difference between serum sRAGE concentrations in diabetic patients with retinopathy and concentrations in diabetic patients free of ocular complications. An unpublished observation of Yonekura et al. (2 ) High ␥-Glutamyltransferase (GGT) Activity in Human Breast Milk Confounds Interpretation of High Serum GGT Activity in a Nursing Infant with Liver Disease
We are writing to reiterate to the medical community that ␥-glutamyltransferase (GGT) activity is high in human breast milk for at least 4 weeks postpartum (1, 2 ) and to suggest that GGT from milk may increase circulating GGT activity in breastfed newborns. An infant was diagnosed with biliary atresia and was surgically managed by a Rouxen-Y hepatoportojejunostomy. The subsequent persistence of high serum GGT activity in the circulation, despite a gradual decrease in the serum bilirubin concentration, prompted concern of an incomplete response to treatment. Because the infant was being breast fed, an alternative explanation for the persistence of the high circulating GGT activity was proposed.
To affirm that breast milk is high in GGT activity and to determine the duration of the increased activity, we evaluated 17 women (16 Caucasian and 1 Hispanic; age range, 25-38 years) during their lactation periods (from 1 day to 17 months postpartum). Procedures were approved by the Institutional Review Board, and informed consent was given by all patients. Breast milk was collected by artificial pump and stored frozen (approximately Ϫ20°C) before analysis. GGT was measured on the Vitros TM 250 Chemistry System (Ortho-Clinical Diagnostics) by a modification of the method of Szasz (3 ). GGT was detectable in all milk samples. The GGT activity in breast milk was high during the first 4 weeks postpartum with values ranging from 1231 to 16 060 U/L with a decreasing trend at week 4 ( Table 1) . The GGT activity of the breast milk of the patient's mother was 1138 U/L at 3 months, the first obtained measurement. The GGT activity in breast milk continued to decrease in all milk samples with an ϳ10-fold decrease in activity from 1 week postpartum to 6 months postpartum (Table 1). The mean values for 2 samples collected 1 and 3 days after delivery in this study was 12 613 U/L, between the mean (SD) value of 22 990 (7263) U/L for colostrum and 4090 (2069) U/L for early breast milk collected on postpartum day 4 in a previous study (2 ) .
High GGT activity in breast milk is not unique to humans. In animals, the circulating GGT concentration is increased in canine pups after the ingestion of colostrum, and the concentration correlates with the passive transfer of immunoglobulin into the circulation of newborn lambs (4, 5 ) . The high GGT activity in human breast milk may reflect activity in the terminal and lactiferous ducts of the breast, which may facilitate the transport of essential proteins into milk (6, 7 ) . Whether GGT facilitates protein absorption by the developing mucosa of the small intestine is not known.
In conclusion, we suggest that the 
